An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination
收藏NIAID Data Ecosystem2026-05-10 收录
数据链接：
官方服务：
资源简介：
Carreno et al. collected human serum samples for the NDV-HXP-S vaccine clinical trial (phase 1) and performed secondary analysis to determine antibody characteristics according to each cohort.
创建时间：
2025-10-30
